調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Medical Image Analysis Software Market by Type (Integrated), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Oncology, Neurology, Mammography, Dental), End User (Hospital, Diagnostic Center) - Global Forecasts to 2027

医用画像分析ソフトウェアのグローバル市場予測（～2027）：統合ソフトウェア、単独ソフトウェア

◆タイトル：Medical Image Analysis Software Market by Type (Integrated), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Oncology, Neurology, Mammography, Dental), End User (Hospital, Diagnostic Center) - Global Forecasts to 2027
◆商品コード：HIT1309-22
◆調査・発行会社：MarketsandMarkets
◆発行日：2022年6月28日
◆ページ数：362
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥0	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥0	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥0	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、世界の医用画像分析ソフトウェア市場規模が、2022年32億ドルから2027年45億ドルまで年平均7.8％成長すると予測しています。本調査資料では、医用画像分析ソフトウェアの世界市場について総合的に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業洞察、種類別（統合ソフトウェア、単独ソフトウェア）分析、画像タイプ別（2D、3D、4D）分析、モダリティ別（トモグラフィ、超音波、放射線、マンモグラフィ、複合モダリティ）分析、用途別（循環器、整形外科、腫瘍、神経、歯科）分析、地域別分析、競争状況、企業情報、隣接市場などの内容をまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業洞察
・世界の医用画像分析ソフトウェア市場規模：種類別（統合ソフトウェア、単独ソフトウェア）
・世界の医用画像分析ソフトウェア市場規模：画像タイプ別（2D、3D、4D）
・世界の医用画像分析ソフトウェア市場規模：モダリティ別（トモグラフィ、超音波、放射線、マンモグラフィ、複合モダリティ）
・世界の医用画像分析ソフトウェア市場規模：用途別（循環器、整形外科、腫瘍、神経、歯科）
・世界の医用画像分析ソフトウェア市場規模：地域別
・競争状況
・企業情報
・隣接市場

“The global medical image analysis software market is projected to reach USD 4.5 Billion by 2027 from USD 3.2 Billion in 2022, at a CAGR of 7.8%.”
Among the factors driving the market are the growing public- and private-sector investments in the medical imaging market, and the rising prevalence of chronic diseases.

“The integrated software was the largest segment in the medical image analysis software market in 2021.”
The integrated software segment accounted for the larger share of 61.8% of the medical image analysis software market in 2021. The growing adoption of imaging systems and imaging tests is one of the major factors driving the growth of the integrated medical image analysis software market during the forecast period.

“Among end users, the hospitals segment accounted for the largest market share in 2021.”
In 2021, the hospitals segment accounted for the largest share of the medical image analysis software market. The rising number of diagnostic imaging procedures performed in hospitals and the increasing adoption of minimally invasive procedures are driving the growth of this end-user segment.

“In 2021, North America accounted for the largest regional market for medical image analysis software market“
In 2021, North America accounted for the largest share of 34.9% of the medical image analysis software market. This can be attributed to the presence of well-established healthcare facilities with advanced diagnostic equipment, favorable government initiatives to support the adoption of healthcare IT, and the presence of key market players, among other factors.
The Asia Pacific region is expected to be the fastest growing region in the forecast period, at a CAGR of 9.2%. The supportive government efforts, growing medical imaging research, and increasing adoption of medical image analysis software by healthcare professionals in the region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type (Supply-side): Tier 1: 40%, Tier 2: 30%, and Tier 3: 30%
• By Designation: C-level: 27%, Director-level: 18%, and Others: 55%
• By Region: North America: 50%, Europe: 20%, Asia-Pacific: 15%, Latin America: 10%, and Middle east & Africa: 5%

Key players offering medical image analysis software products in this market include GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Inc. (Japan), Agfa HealthCare (Belgium), International Business Machines Corporation (US), Carestream Health, Inc. (US), AQUILAB SAS (France), Esaote S.p.A. (Italy), MIM Software, Inc. (US), Image Analysis, Ltd. (UK), and ScienceSoft USA Corporation (US).

Research Coverage:
The report analyzes the medical image analysis software market and aims at estimating the market size and future growth potential of this market based on various segments such as product, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the medical image analysis software market. The report analyzes the market based on the products, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the medical image analysis software market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of medical image analysis software solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the medical image analysis software market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the medical image analysis software markets.

【レポートの目次】

1 INTRODUCTION 46
1.1 STUDY OBJECTIVES 46
1.2 MARKET DEFINITION 47
1.2.1 INCLUSIONS AND EXCLUSIONS 47
1.3 MARKET SCOPE 48
1.3.1 MARKETS COVERED 48
FIGURE 1 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SEGMENTATION 48
1.3.2 YEARS CONSIDERED 49
1.4 CURRENCY 49
1.5 LIMITATIONS 49
1.6 STAKEHOLDERS 50
1.7 SUMMARY OF CHANGES 50
2 RESEARCH METHODOLOGY 51
2.1 RESEARCH APPROACH 51
2.2 RESEARCH METHODOLOGY DESIGN 51
FIGURE 2 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: RESEARCH DESIGN 51
2.2.1 SECONDARY RESEARCH 52
2.2.1.1 Key data from secondary sources 53
2.2.2 PRIMARY DATA 53
FIGURE 3 PRIMARY SOURCES 53
2.2.2.1 Key data from primary sources 54
2.2.2.2 Insights from primary experts 55
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND- SIDE PARTICIPANTS 55
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 56
2.3 MARKET SIZE ESTIMATION: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 56
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 57
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2021) 57
FIGURE 8 TOP-DOWN APPROACH 58
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2022–2027) 59
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 60
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 61
FIGURE 11 DATA TRIANGULATION METHODOLOGY 61
2.5 MARKET SHARE ESTIMATION 62
2.6 ASSUMPTIONS FOR THE STUDY 62
2.7 RISK ASSESSMENT 63
TABLE 1 LIMITATIONS & ASSOCIATED RISKS 63
3 EXECUTIVE SUMMARY 64
FIGURE 12 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 64
FIGURE 13 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2022 VS. 2027 (USD MILLION) 65
FIGURE 14 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2022 VS. 2027 (USD MILLION) 65
FIGURE 15 TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 66
FIGURE 16 ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 67
FIGURE 17 COMBINED MODALITY IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 67
FIGURE 18 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 68
FIGURE 19 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 69
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 70
4 PREMIUM INSIGHTS 71
4.1 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET OVERVIEW 71
FIGURE 21 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL IMAGING SYSTEMS AND ANALYSIS SOFTWARE TO DRIVE MARKET GROWTH 71
4.2 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 72
FIGURE 22 CHINA TO WITNESS HIGHEST GROWTH IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET DURING FORECAST PERIOD 72
4.3 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE AND COUNTRY (2021) 73
FIGURE 23 INTEGRATED SOFTWARE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET IN 2021 73
4.4 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY AND COUNTRY (2021) 74
FIGURE 24 TOMOGRAPHY SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET IN 2021 74
4.5 REGIONAL MIX: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2022–2027) 75
FIGURE 25 ASIA PACIFIC REGION TO WITNESS HIGHEST GROWTH BETWEEN 2022 AND 2027 75
4.6 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DEVELOPED VS. DEVELOPING MARKETS 75
FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 75
5 MARKET OVERVIEW 76
5.1 INTRODUCTION 76
5.2 MARKET DYNAMICS 77
FIGURE 27 MARKET DYNAMICS: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 77
5.2.1 DRIVERS 77
5.2.1.1 Technological advancements in medical imaging systems and analysis software 77
5.2.1.2 Growing public- and private-sector investments in medical imaging market 78
TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN DIAGNOSTIC IMAGING MARKET 78
5.2.1.3 Rising prevalence of chronic diseases 79
FIGURE 28 PREVALENCE OF CHRONIC DISEASE-RELATED DEATHS IN DEVELOPED AND DEVELOPING COUNTRIES (2020) 79
FIGURE 29 NUMBER OF CT AND MRI SCANNERS PER MILLION POPULATION, BY COUNTRY (2019) 80
5.2.1.4 Growing applications of computer-aided diagnosis 80
5.2.2 RESTRAINTS 81
5.2.2.1 Budgetary constraints 81
5.2.3 OPPORTUNITIES 81
5.2.3.1 Cloud-based image analysis solutions 81
5.2.3.2 Untapped emerging markets 82
TABLE 3 INSTALLED BASE OF CT, MRI, AND PET-CT IN ASIAN COUNTRIES (2015) 82
TABLE 4 NUCLEAR MEDICINE INFRASTRUCTURE IN ASIAN AND MIDDLE EASTERN COUNTRIES (2015) 82
5.2.4 CHALLENGES 83
5.2.4.1 Market penetration of standalone software vendors 83
5.2.4.2 Software security and compliance issues 83
FIGURE 30 NUMBER OF DATA BREACHES IN THE US (2010–2020) 83
TABLE 5 LARGEST HEALTHCARE DATA BREACHES IN THE WORLD (2020-2021) 84
5.2.4.3 Shortage of radiologists 85
5.3 KEY CONFERENCES & EVENTS IN 2022–2023 86
TABLE 6 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS 86
5.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 11 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
6 INDUSTRY INSIGHTS 92
6.1 INTRODUCTION 92
6.2 INDUSTRY TRENDS 92
6.2.1 ADOPTION OF HYBRID MEDICAL IMAGING MODALITIES 92
6.2.2 SHIFT TO 3D IMAGING 92
6.2.3 CLOUD COMPUTING 93
6.2.4 ARTIFICIAL INTELLIGENCE (AI) 93
6.3 TECHNOLOGY TRENDS 93
6.3.1 MACHINE LEARNING, ARTIFICIAL INTELLIGENCE, AND COMPUTER-AIDED DESIGN IN MEDICAL IMAGE ANALYSIS 93
6.4 SUPPLY CHAIN ANALYSIS 94
FIGURE 31 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: STAKEHOLDERS IN SUPPLY CHAIN 95
6.5 ECOSYSTEM MAPPING 95
FIGURE 32 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: ECOSYSTEM ANALYSIS 96
6.6 PORTER’S FIVE FORCES ANALYSIS 96
TABLE 12 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS 96
6.6.1 THREAT OF NEW ENTRANTS 97
6.6.1.1 Capital requirement 97
6.6.1.2 High preference for products from well-established brands 97
6.6.2 THREAT OF SUBSTITUTES 97
6.6.2.1 Substitutes for medical image analysis software 97
6.6.3 BARGAINING POWER OF SUPPLIERS 98
6.6.3.1 Presence of several raw material suppliers 98
6.6.3.2 Supplier switching costs 98
6.6.4 BARGAINING POWER OF BUYERS 98
6.6.4.1 Few companies offer premium products at global level 98
6.6.5 INTENSITY OF COMPETITIVE RIVALRY 98
6.6.5.1 Increasing demand for high-quality and innovative products 98
6.6.5.2 Lucrative growth potential in emerging markets 99
6.7 PATENT ANALYSIS 99
6.7.1 PATENT PUBLICATION TRENDS FOR MEDICAL IMAGE ANALYSIS SOFTWARE 99
FIGURE 33 GLOBAL PATENT PUBLICATION TRENDS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2018–2022 99
6.7.2 TOP APPLICANTS (COMPANIES) FOR MEDICAL IMAGE ANALYSIS SOFTWARE PATENTS 100
FIGURE 34 TOP COMPANIES THAT APPLIED FOR MEDICAL IMAGE ANALYSIS SOFTWARE PATENTS, 2018–2022 100
6.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 100
FIGURE 35 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MEDICAL IMAGE ANALYSIS SOFTWARE PATENTS, 2018–2022 100

6.8 REGULATORY ANALYSIS 101
6.8.1 NORTH AMERICA 101
6.8.2 EUROPE 102
6.8.3 ASIA PACIFIC 102
6.8.4 MIDDLE EAST & AFRICA 103
6.8.5 LATIN AMERICA 103
6.9 PRICING ANALYSIS 103
TABLE 13 COMMERCIAL PRICING (USD) 104
TABLE 14 ACADEMIC PRICING (USD) 104
TABLE 15 REGIONAL PRICING ANALYSIS OF KEY DIAGNOSTIC IMAGING MODALITIES, 2020 (USD) 104
6.10 TRADE ANALYSIS 105
6.10.1 TRADE ANALYSIS FOR COMPUTED TOMOGRAPHY SYSTEMS 105
TABLE 16 IMPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION) 105
TABLE 17 EXPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION) 106
6.10.2 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS 106
TABLE 18 IMPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION) 106
TABLE 19 EXPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION) 107
6.10.3 TRADE ANALYSIS FOR MAGNETIC RESONANCE IMAGING SYSTEMS 107
TABLE 20 IMPORT DATA FOR MAGNETIC RESONANCE IMAGING SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION) 107
TABLE 21 EXPORT DATA FOR MAGNETIC RESONANCE IMAGING SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION) 108
6.10.4 TRADE ANALYSIS FOR X-RAY SYSTEMS 108
TABLE 22 IMPORT DATA FOR X-RAY SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION) 108
TABLE 23 EXPORT DATA FOR X-RAY SYSTEMS, BY COUNTRY, 2016–2020 (USD MILLION) 109
6.11 IMPACT OF COVID-19 ON MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 109
7 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE 110
7.1 INTRODUCTION 111
TABLE 24 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 25 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 112
7.2 INTEGRATED SOFTWARE 112
7.2.1 INTEGRATED SOFTWARE IS LARGEST & FASTEST-GROWING SEGMENT OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 112
TABLE 26 INTEGRATED MEDICAL IMAGE ANALYSIS SOFTWARE VENDORS 113
TABLE 27 INTEGRATED IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 114
7.3 STANDALONE SOFTWARE 115
7.3.1 STANDALONE SOFTWARE OFFERS HIGHER FLEXIBILITY WITH NUMEROUS FEATURES 115
TABLE 28 STANDALONE MEDICAL IMAGE ANALYSIS SOFTWARE VENDORS 115
TABLE 29 STANDALONE IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116
8 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE 117
8.1 INTRODUCTION 118
TABLE 30 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 118
8.2 3D IMAGING 118
8.2.1 GROWING ACCEPTANCE AND RISING ADVANTAGES OF THIS TECHNIQUE ARE SUPPORTING MARKET GROWTH 118
TABLE 31 3D IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 119
TABLE 32 3D IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
8.3 4D IMAGING 120
8.3.1 4D MEDICAL IMAGING IS REPLACING TRADITIONAL SURGICAL INTERVENTIONS BY PROVIDING MINIMALLY INVASIVE ALTERNATIVES 120
TABLE 33 4D IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 121
TABLE 34 4D IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121
8.4 2D IMAGING 122
8.4.1 2D IMAGING IS COST-EFFECTIVE, SIMPLE, FAST, AND EASY TO PERFORM 122
TABLE 35 2D IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 122
TABLE 36 2D IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 124
9 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY 125
9.1 INTRODUCTION 126
TABLE 37 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 126
9.2 TOMOGRAPHY 127
TABLE 38 TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 39 TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 128
9.2.1 COMPUTED TOMOGRAPHY (CT) 128
TABLE 40 CT IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 129
TABLE 41 COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 42 COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
9.2.1.1 High-end slice CT 131
9.2.1.1.1 Increasing R&D investments by market players to drive market growth 131
TABLE 43 HIGH-END SLICE CT IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
9.2.1.2 Mid-end slice CT 133
9.2.1.2.1 Uncertain reimbursements and insurance coverage in developing countries to restrain market growth 133
TABLE 44 MID-END SLICE CT IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 134
9.2.1.3 Low-end slice CT 134
9.2.1.3.1 Low cost and significant demand in emerging markets to drive market 134
TABLE 45 LOW-END SLICE CT IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 135
9.2.2 MAGNETIC RESONANCE IMAGING (MRI) 135
TABLE 46 MAGNETIC RESONANCE IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 136
TABLE 47 MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 48 MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 137
9.2.2.1 Closed MRI systems 138
9.2.2.1.1 Increasing prevalence of brain-related disorders/diseases propelling market growth 138
TABLE 49 CLOSED MRI ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 139
9.2.2.2 Open MRI systems 139
9.2.2.2.1 Open MRI systems work on same principle as traditional MRI systems 139
TABLE 50 OPEN MRI ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 140
9.2.3 POSITRON EMISSION TOMOGRAPHY (PET) 140
9.2.3.1 Increasing shift from standalone PET scans to combined modalities like PET/CT and PET/MR 140
TABLE 51 PET IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 141
TABLE 52 POSITRON EMISSION TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 142
9.2.4 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 142
9.2.4.1 Growing prevalence of chronic neurological disorders to increase usage of SPECT scans 142
TABLE 53 SPECT IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 143
TABLE 54 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 144
9.3 ULTRASOUND IMAGING 144
TABLE 55 ULTRASOUND IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 145
TABLE 56 ULTRASOUND IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 57 ULTRASOUND IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 146
9.3.1 2D ULTRASOUND SYSTEMS 146
9.3.1.1 Higher resolution of 2D imaging systems to increase their adoption 146
TABLE 58 ULTRASOUND 2D IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 147
9.3.2 3D AND 4D ULTRASOUND SYSTEMS 148
9.3.2.1 Growing number of products launches with technological and software modifications propelling market growth 148
TABLE 59 ULTRASOUND 3D AND 4D IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 149
9.3.3 DOPPLER IMAGING 149
9.3.3.1 Technological developments by market players in Doppler imaging to aid market growth 149
TABLE 60 DOPPLER IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
9.4 RADIOGRAPHIC IMAGING 151
9.4.1 INCREASED ADOPTION OF RADIOGRAPHIC IMAGING TECHNIQUES DUE TO COVID-19 PANDEMIC TO DRIVE MARKET 151
TABLE 61 RADIOGRAPHIC IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 152
TABLE 62 RADIOGRAPHIC IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153
9.5 COMBINED MODALITIES 154
FIGURE 36 COMBINED PET SCANNERS PER MILLION POPULATION, BY COUNTRY (2019) 154
TABLE 63 COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 64 COMBINED MODALITY IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 155
9.5.1 PET/CT 155
9.5.1.1 PET/CT is more powerful than standalone PET systems 155
TABLE 65 PET/CT IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 156
TABLE 66 PET/CT IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 156
9.5.2 SPECT/CT 157
9.5.2.1 Growing number of new product launches to drive market 157
TABLE 67 SPECT/CT IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 157
TABLE 68 SPECT/CT IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 158
9.5.3 PET/MR 158
9.5.3.1 PET/MR is more effective than PET/CT as it offers less radiation exposure and higher contrast 158
TABLE 69 PET/MR IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 159
TABLE 70 PET/MR IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 159
9.6 MAMMOGRAPHY 160
9.6.1 INCREASING INCIDENCE OF BREAST CANCER TO DRIVE MARKET 160
TABLE 71 MAMMOGRAPHY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 160
TABLE 72 MAMMOGRAPHY IMAGING ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 161
10 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION 162
10.1 INTRODUCTION 163
TABLE 73 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 163
10.2 CARDIOLOGY 163
10.2.1 RISING INCIDENCE OF CARDIAC DISORDERS TO DRIVE MARKET 163
TABLE 74 CARDIOLOGY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 164
TABLE 75 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 165
10.3 ORTHOPEDICS 166
10.3.1 RISING ARTHRITIS CASES SUPPORTING MARKET GROWTH 166
TABLE 76 ORTHOPEDIC IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 166
TABLE 77 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDICS, BY COUNTRY, 2020–2027 (USD MILLION) 167
10.4 ONCOLOGY 167
10.4.1 GROWING NUMBER OF CANCER CASES TO DRIVE MARKET 167
TABLE 78 ONCOLOGY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 168
TABLE 79 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 169
10.5 NEUROLOGY 169
10.5.1 INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES DRIVING GROWTH OF THIS SEGMENT 169
TABLE 80 NEUROLOGY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 170
TABLE 81 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 171
10.6 OBSTETRICS AND GYNECOLOGY 171
10.6.1 MRI WIDELY USED IMAGING TECHNIQUE IN OBSTETRICS AND GYNECOLOGY 171
TABLE 82 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OBSTETRICS AND GYNECOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 172
10.7 MAMMOGRAPHY 173
10.7.1 INCREASING DEMAND FOR EFFICIENCY IN BREAST IMAGING TO DRIVE MARKET 173
TABLE 83 MAMMOGRAPHY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 174
TABLE 84 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2020–2027 (USD MILLION) 174
10.8 DENTAL 175
10.8.1 INCREASING PREVALENCE OF OROPHARYNGEAL CANCER TO SUPPORT MARKET GROWTH 175
TABLE 85 DENTAL IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 176
TABLE 86 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 176

10.9 RESPIRATORY 177
10.9.1 COVID-19 PANDEMIC HAS INCREASED DEMAND FOR X-RAY IMAGING 177
TABLE 87 RESPIRATORY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 178
TABLE 88 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR RESPIRATORY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 178
10.10 UROLOGY AND NEPHROLOGY 179
10.10.1 RISING INCIDENCE OF KIDNEY DISEASE DRIVING UROLOGY AND NEPHROLOGY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 179
TABLE 89 UROLOGY AND NEPHROLOGY IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 179
TABLE 90 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR UROLOGY AND NEPHROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 180
10.11 VASCULAR 180
10.11.1 RISING INCIDENCE OF VASCULAR DISORDERS TO PROPEL MARKET GROWTH 180
TABLE 91 VASCULAR IMAGE ANALYSIS SOFTWARE OFFERED BY KEY PLAYERS 181
TABLE 92 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR VASCULAR APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 182
11 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER 183
11.1 INTRODUCTION 184
TABLE 93 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 184
11.2 HOSPITALS 184
11.2.1 HIGH ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE MARKET 184
FIGURE 37 NUMBER OF HOSPITALS, BY COUNTRY (2019) 185
TABLE 94 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 186
11.3 DIAGNOSTIC IMAGING CENTERS 186
11.3.1 LOWER WAITING PERIOD IN DIAGNOSTIC IMAGING CENTERS AND QUICKER RESULTS ARE SUPPORTING GROWTH OF THIS SEGMENT 186
TABLE 95 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 187
11.4 OTHER END USERS 187
FIGURE 38 US: NUMBER OF AMBULATORY SURGERY CENTERS (2012–2022) 188
TABLE 96 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 189
12 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION 190
12.1 INTRODUCTION 191
FIGURE 39 CHINA TO WITNESS HIGHEST GROWTH IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET DURING FORECAST PERIOD 191
TABLE 97 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 192
12.2 NORTH AMERICA 192
FIGURE 40 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SNAPSHOT 193
TABLE 98 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 193
TABLE 99 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 100 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 194
TABLE 101 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 194
TABLE 102 NORTH AMERICA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 103 NORTH AMERICA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 104 NORTH AMERICA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 105 NORTH AMERICA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 106 NORTH AMERICA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 107 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 197
TABLE 108 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 197
12.2.1 US 198
12.2.1.1 Growth of medical technologies industry to support market growth 198
TABLE 109 US: KEY MACROINDICATORS 198
TABLE 110 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 111 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 199
TABLE 112 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 200
TABLE 113 US: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 114 US: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 115 US: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 116 US: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 117 US: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 118 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 202
TABLE 119 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 203
12.2.2 CANADA 203
12.2.2.1 Growing investments in medical imaging field to drive market 203
TABLE 120 CANADA: KEY MACROINDICATORS 204
TABLE 121 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 122 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 205
TABLE 123 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 205
TABLE 124 CANADA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 125 CANADA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 126 CANADA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 206
TABLE 127 CANADA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 128 CANADA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 129 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 208
TABLE 130 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 208
12.3 EUROPE 209
TABLE 131 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 209
TABLE 132 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 133 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 210
TABLE 134 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 210
TABLE 135 EUROPE: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 136 EUROPE: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 137 EUROPE: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 138 EUROPE: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 139 EUROPE: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 140 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 213
TABLE 141 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 213
12.3.1 GERMANY 214
12.3.1.1 High adoption of diagnostic imaging systems and strong healthcare infrastructure to drive market in Germany 214
TABLE 142 GERMANY: KEY MACROINDICATORS 214
TABLE 143 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 214
TABLE 144 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 215
TABLE 145 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 215
TABLE 146 GERMANY: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 147 GERMANY: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 148 GERMANY: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 149 GERMANY: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 150 GERMANY: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 151 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 218
TABLE 152 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 218
12.3.2 FRANCE 219
12.3.2.1 Growing public-private investments and rising number of imaging centers to support market growth 219
TABLE 153 FRANCE: KEY MACROINDICATORS 219
TABLE 154 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 220
TABLE 155 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 220
TABLE 156 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 220
TABLE 157 FRANCE: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 158 FRANCE: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 159 FRANCE: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 160 FRANCE: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 222
TABLE 161 FRANCE: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 222
TABLE 162 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 223
TABLE 163 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 223
12.3.3 UK 224
12.3.3.1 Rising demand for medical imaging procedures to support market growth 224
TABLE 164 UK: KEY MACROINDICATORS 224
TABLE 165 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 225
TABLE 166 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 225
TABLE 167 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 225
TABLE 168 UK: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 226
TABLE 169 UK: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 226
TABLE 170 UK: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 226
TABLE 171 UK: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 227
TABLE 172 UK: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 227
TABLE 173 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 228
TABLE 174 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 228
12.3.4 SPAIN 229
12.3.4.1 Favorable regulatory scenario and rising geriatric population are key growth drivers 229
TABLE 175 SPAIN: KEY MACROINDICATORS 229
TABLE 176 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 230
TABLE 177 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 230
TABLE 178 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 230
TABLE 179 SPAIN: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 231
TABLE 180 SPAIN: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 231
TABLE 181 SPAIN: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 231
TABLE 182 SPAIN: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 232
TABLE 183 SPAIN: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 232
TABLE 184 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 233
TABLE 185 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 233
12.3.5 ITALY 234
12.3.5.1 Well-established healthcare infrastructure to support overall market growth 234
TABLE 186 ITALY: KEY MACROINDICATORS 234
TABLE 187 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 234
TABLE 188 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 235
TABLE 189 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 235
TABLE 190 ITALY: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 191 ITALY: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 192 ITALY: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 193 ITALY: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 194 ITALY: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 195 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 238
TABLE 196 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 238
12.3.6 REST OF EUROPE 239
TABLE 197 ROE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 239
TABLE 198 ROE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 239
TABLE 199 ROE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 240
TABLE 200 ROE: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 240
TABLE 201 ROE: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 241
TABLE 202 ROE: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 241
TABLE 203 ROE: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 241
TABLE 204 ROE: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 242
TABLE 205 ROE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 242
TABLE 206 ROE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 243

12.4 ASIA PACIFIC 243
FIGURE 41 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SNAPSHOT 244
TABLE 207 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 245
TABLE 208 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 245
TABLE 209 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 245
TABLE 210 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 246
TABLE 211 ASIA PACIFIC: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 246
TABLE 212 ASIA PACIFIC: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 247
TABLE 213 ASIA PACIFIC: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 247
TABLE 214 ASIA PACIFIC: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 247
TABLE 215 ASIA PACIFIC: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 248
TABLE 216 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 248
TABLE 217 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 249
12.4.1 JAPAN 249
12.4.1.1 Technological advancements to aid market growth 249
TABLE 218 JAPAN: KEY MACROINDICATORS 250
TABLE 219 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 250
TABLE 220 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 250
TABLE 221 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 251
TABLE 222 JAPAN: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 251
TABLE 223 JAPAN: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 252
TABLE 224 JAPAN: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 252
TABLE 225 JAPAN: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 252
TABLE 226 JAPAN: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 253
TABLE 227 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 253
TABLE 228 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 254
12.4.2 CHINA 254
12.4.2.1 Strong government support for healthcare reforms and increasing number of medical imaging procedures to drive market 254
TABLE 229 CHINA: KEY MACROINDICATORS 255
TABLE 230 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 255
TABLE 231 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 255
TABLE 232 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 256
TABLE 233 CHINA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 256
TABLE 234 CHINA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 257
TABLE 235 CHINA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 257
TABLE 236 CHINA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 257
TABLE 237 CHINA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 258
TABLE 238 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 258
TABLE 239 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 259
12.4.3 INDIA 259
12.4.3.1 Improving healthcare infrastructure to support growth of medical image analysis software market in India 259
TABLE 240 INDIA: KEY MACROINDICATORS 260
TABLE 241 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 260
TABLE 242 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 260
TABLE 243 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 261
TABLE 244 INDIA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 261
TABLE 245 INDIA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 262
TABLE 246 INDIA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 262
TABLE 247 INDIA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 262
TABLE 248 INDIA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 263
TABLE 249 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 263
TABLE 250 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 264
12.4.4 REST OF ASIA PACIFIC 264
TABLE 251 ROAPAC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 265
TABLE 252 ROAPAC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 265
TABLE 253 ROAPAC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 265
TABLE 254 ROAPAC: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 266
TABLE 255 ROAPAC: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 266
TABLE 256 ROAPAC: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 266
TABLE 257 ROAPAC: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 267
TABLE 258 ROAPAC: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 267
TABLE 259 ROAPAC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 268
TABLE 260 ROAPAC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 268
12.5 LATIN AMERICA 269
TABLE 261 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 269
TABLE 262 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 269
TABLE 263 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 270
TABLE 264 LATIN AMERICA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 270
TABLE 265 LATIN AMERICA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 271
TABLE 266 LATIN AMERICA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 271
TABLE 267 LATIN AMERICA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 271
TABLE 268 LATIN AMERICA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 272
TABLE 269 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 272
TABLE 270 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 273
12.5.1 BRAZIL 273
12.5.1.1 Growing disease burden and rising awareness to drive market for medical image analysis software 273
TABLE 271 BRAZIL: KEY MACROINDICATORS 274
TABLE 272 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 274
TABLE 273 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 274
TABLE 274 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 275
TABLE 275 BRAZIL: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 275
TABLE 276 BRAZIL: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 276
TABLE 277 BRAZIL: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 276
TABLE 278 BRAZIL: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 276
TABLE 279 BRAZIL: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 277
TABLE 280 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 277
TABLE 281 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 278
12.5.2 MEXICO 278
12.5.2.1 Government initiatives to boost adoption of medical image analysis software solutions 278
TABLE 282 MEXICO: KEY MACROINDICATORS 279
TABLE 283 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 279
TABLE 284 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 279
TABLE 285 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 280
TABLE 286 MEXICO: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 280
TABLE 287 MEXICO: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 281
TABLE 288 MEXICO: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 281
TABLE 289 MEXICO: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 281
TABLE 290 MEXICO: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 282
TABLE 291 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 282
TABLE 292 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 283
12.5.3 REST OF LATIN AMERICA 283
TABLE 293 ROLATAM: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 283
TABLE 294 ROLATAM: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 284
TABLE 295 ROLATAM: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 284
TABLE 296 ROLATAM: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 285
TABLE 297 ROLATAM: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 285
TABLE 298 ROLATAM: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 285
TABLE 299 ROLATAM: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 286
TABLE 300 ROLATAM: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 286
TABLE 301 ROLATAM: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 287
TABLE 302 ROLATAM: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 287
12.6 MIDDLE EAST & AFRICA 288
12.6.1 INCREASING INVESTMENTS TO MODERNIZE HEALTHCARE SYSTEMS BOOSTS MARKET GROWTH 288
TABLE 303 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 288
TABLE 304 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2020–2027 (USD MILLION) 289
TABLE 305 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2020–2027 (USD MILLION) 289
TABLE 306 MIDDLE EAST & AFRICA: TOMOGRAPHIC IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 290
TABLE 307 MIDDLE EAST & AFRICA: COMPUTED TOMOGRAPHY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 290
TABLE 308 MIDDLE EAST & AFRICA: MAGNETIC RESONANCE IMAGING ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 290
TABLE 309 MIDDLE EAST & AFRICA: ULTRASOUND IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 291
TABLE 310 MIDDLE EAST & AFRICA: COMBINED MODALITY IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2020–2027 (USD MILLION) 291
TABLE 311 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 292
TABLE 312 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2020–2027 (USD MILLION) 292
13 COMPETITIVE LANDSCAPE 293
13.1 OVERVIEW 293
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 293
TABLE 313 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 294
13.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 296
FIGURE 42 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 296
13.4 COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS 297
TABLE 314 OVERALL FOOTPRINT OF COMPANIES 297
TABLE 315 PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES) 298
TABLE 316 END-USER FOOTPRINT OF COMPANIES (26 COMPANIES) 299
TABLE 317 REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES) 300
13.5 COMPANY EVALUATION QUADRANT 301
13.5.1 STARS 301
13.5.2 EMERGING LEADERS 302
13.5.3 PERVASIVE PLAYERS 302
13.5.4 PARTICIPANTS 302
FIGURE 43 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING (2021) 303

13.6 STARTUP/SME EVALUATION QUADRANT 304
TABLE 318 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 304
13.6.1 PROGRESSIVE COMPANIES 305
13.6.2 DYNAMIC COMPANIES 305
13.6.3 STARTING BLOCKS 305
13.6.4 RESPONSIVE COMPANIES 305
FIGURE 44 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUP COMPANIES (2021) 306
13.7 KEY STAKEHOLDERS & BUYING CRITERIA 307
13.7.1 KEY STAKEHOLDERS IN BUYING PROCESS 307
FIGURE 45 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MEDICAL IMAGE ANALYSIS SOFTWARE 307
TABLE 319 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MEDICAL IMAGE ANALYSIS SOFTWARE 307
13.7.2 BUYING CRITERIA 308
FIGURE 46 KEY BUYING CRITERIA FOR MEDICAL IMAGE ANALYSIS SOFTWARE 308
TABLE 320 KEY BUYING CRITERIA FOR MEDICAL IMAGE ANALYSIS SOFTWARE 308
13.8 MARKET RANKING ANALYSIS 308
FIGURE 47 LEADING PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2021) 309
13.9 COMPETITIVE SCENARIO 310
13.9.1 PRODUCT LAUNCHES & APPROVALS 310
TABLE 321 PRODUCT LAUNCHES AND APPROVALS, JANUARY 2018–MAY 2022 310
13.9.2 DEALS 311
TABLE 322 DEALS, JANUARY 2018–MAY 2022 311
14 COMPANY PROFILES 313
14.1 KEY PLAYERS 313
(Business Overview, Products Offered, Recent Developments, Deals, MnM view, Right to win, Strategic choices made, Weakness competitive threats)*
14.1.1 GE HEALTHCARE 313
TABLE 323 GE HEALTHCARE: BUSINESS OVERVIEW 313
FIGURE 48 GE HEALTHCARE: COMPANY SNAPSHOT (2021) 314
14.1.2 KONINKLIJKE PHILIPS N.V. 318
TABLE 324 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 318
FIGURE 49 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021) 319
14.1.3 SIEMENS HEALTHINEERS 322
TABLE 325 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 322
FIGURE 50 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021) 323
14.1.4 CANON INC. 328
TABLE 326 CANON INC.: BUSINESS OVERVIEW 328
FIGURE 51 CANON INC.: COMPANY SNAPSHOT (2021) 329
14.1.5 AGFA HEALTHCARE (AGFA-GEVAERT GROUP) 331
TABLE 327 AGFA HEALTHCARE (AGFA-GEVAERT GROUP): BUSINESS OVERVIEW 331
FIGURE 52 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2021) 332
14.1.6 INTERNATIONAL BUSINESS MACHINES (IBM) CORPORATION 335
TABLE 328 IBM: BUSINESS OVERVIEW 335
FIGURE 53 IBM: COMPANY SNAPSHOT (2021) 336
14.1.7 CARESTREAM HEALTH 339
TABLE 329 CARESTREAM HEALTH: BUSINESS OVERVIEW 339
FIGURE 54 ONEX CORPORATION: COMPANY SNAPSHOT (2021) 340
14.1.8 AQUILAB SAS 342
TABLE 330 AQUILAB SAS: BUSINESS OVERVIEW 342
14.1.9 ESAOTE S.P.A. 344
TABLE 331 ESAOTE S.P.A.: BUSINESS OVERVIEW 344
14.1.10 MIM SOFTWARE INC. 346
TABLE 332 MIM SOFTWARE INC.: BUSINESS OVERVIEW 346
14.1.11 IMAGE ANALYSIS, LTD. 347
TABLE 333 IMAGE ANALYSIS, LTD.: BUSINESS OVERVIEW 347
14.1.12 SCIENCESOFT USA CORPORATION 348
TABLE 334 SCIENCESOFT USA CORPORATION: BUSINESS OVERVIEW 348
14.1.13 XINAPSE SYSTEMS LTD 349
TABLE 335 XINAPSE SYSTEMS LTD: BUSINESS OVERVIEW 349
14.1.14 INFINITT HEALTHCARE CO., LTD. 350
TABLE 336 INFINITT HEALTHCARE CO. LTD.: BUSINESS OVERVIEW 350
14.1.15 DENTSPLY SIRONA 352
TABLE 337 DENTSPLY SIRONA: BUSINESS OVERVIEW 352
FIGURE 55 DENTSPLY SIRONA: COMPANY SNAPSHOT (2021) 353
14.1.16 MEDIS MEDICAL IMAGING SYSTEMS BV 354
TABLE 338 MEDIS MEDICAL IMAGING SYSTEMS BV: BUSINESS OVERVIEW 354
14.1.17 NEUSOFT MEDICAL SYSTEMS CO., LTD. 355
TABLE 339 NEUSOFT MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW 355
FIGURE 56 NEUSOFT CORPORATION: COMPANY SNAPSHOT (2021) 355
14.1.18 PLANMECA OY 357
TABLE 340 PLANMECA OY: BUSINESS OVERVIEW 357
14.1.19 ANALYZEDIRECT, INC. 359
TABLE 341 ANALYZEDIRECT, INC.: BUSINESS OVERVIEW 359
14.1.20 ARTERYS INC. 360
TABLE 342 ARTERYS, INC.: BUSINESS OVERVIEW 360
14.1.21 MEDIA CYBERNETICS, INC. 362
TABLE 343 MEDIA CYBERNETICS: BUSINESS OVERVIEW 362
*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Right to win, Strategic choices made, Weakness competitive threats might not be captured in case of unlisted companies.

14.2 OTHER PLAYERS 363
14.2.1 QMENTA 363
14.2.2 CEFLA MEDICAL EQUIPMENT (CEFLA S.C.) 363
14.2.3 ZIOSOFT 364
14.2.4 KITWARE, INC. 364
14.2.5 LUNIT INC. 365
15 APPENDIX 366
15.1 DISCUSSION GUIDE 366
15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 372
15.3 AVAILABLE CUSTOMIZATION 374
15.4 RELATED REPORTS 374
15.5 AUTHOR DETAILS 375

★調査レポート[医用画像分析ソフトウェアのグローバル市場予測（～2027）：統合ソフトウェア、単独ソフトウェア] ( Medical Image Analysis Software Market by Type (Integrated), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Oncology, Neurology, Mammography, Dental), End User (Hospital, Diagnostic Center) - Global Forecasts to 2027 / HIT1309-22) 販売に関する免責事項

[医用画像分析ソフトウェアのグローバル市場予測（～2027）：統合ソフトウェア、単独ソフトウェア] ( Medical Image Analysis Software Market by Type (Integrated), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Oncology, Neurology, Mammography, Dental), End User (Hospital, Diagnostic Center) - Global Forecasts to 2027 / HIT1309-22) についてEメールでお問い合わせ

◆関連調査資料◆

電気生理の世界市場予測（～2027）：製品別、疾患別、エンドユーザー別
MD3273-22 / MarketsandMarkets / 2022年3月2日 / マーケッツアンドマーケッツ社は、2021年に68億ドルであった世界の電気生理市場規模が、2022年から2027年の間に年平均9.4％成長し、2027年までに116億ドル達すると予測しています。本調査レポートは、電気生理の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（ラボ用デバイス、アブレーションカテーテル、診断カテーテル）分析、疾患別（心房細動、心房粗動、心房室結節性頻脈（AVNRT）、ウォルフ・パーキンソン・ホワイト症候群（WPW）、その他）分析、エンドユーザー別（病院・心臓センター、外来手術センター）分析、地域別分析、競争状況、企業情報など、以下の構成でまとめております。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・世界の電気生理市場規模：製品別（ラボ用デバイス、アブレーションカテーテル、診断カテーテル）・世界の電気生理市場規模：疾患別（心房細動、心房粗動、心房室結節性頻脈（AVNRT）、ウォルフ・パーキンソン・ホワイト症候群（WPW）、その他）・世界の電気生理市場規模：エンドユーザー別（病院・心臓センター、外来手術センター）・世界の電気生理市場規模：地域別...“The global electrophysiology market is projected to reach USD 11.6 billion by 2027 from USD 6.8 billion in 2021, at a CAGR of 9.4% during the forecast period of 2022 to 2027.” An electrophysiology (EP) test is conducted to study the electrical activities and electrical pathways of the patient’s heart to diagnose and treat complex cardiac diseases. It enables electrophysiologists to understand the cause of heart rhythm disturbances and suggest the required treatment. Electrophysiology (EP) is defined as the heart’s electrical system that is being studied to analyze and diagnose its electrical activities. Cardiac electrophysiology studies the phenomena by recording...

幹細胞アッセイのグローバル市場予測（～2027）：生存率、増殖、分化、アポトーシス
BT4628-22 / MarketsandMarkets / 2022年6月21日 / マーケッツアンドマーケッツ社は、世界の幹細胞アッセイ市場規模が、2022年19億ドルから2027年45億ドルまで年平均17.7％成長すると予測しています。本調査資料では、幹細胞アッセイの世界市場について総合的に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（生存率/細胞毒性、分離＆精製、細胞識別、増殖、分化）分析、細胞種類別（成体幹細胞、ヒト胚性幹細胞）分析、製品・サービス別（機器、キット、サービス）分析、用途別（再生医療＆治療法開発、創薬＆開発、臨床研究）分析、地域別分析、競争状況、企業情報などの内容をまとめております。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・世界の幹細胞アッセイ市場規模：種類別（生存率/細胞毒性、分離＆精製、細胞識別、増殖、分化）・世界の幹細胞アッセイ市場規模：細胞種類別（成体幹細胞、ヒト胚性幹細胞）・世界の幹細胞アッセイ市場規模：製品・サービス別（機器、キット、サービス）・世界の幹細胞アッセイ市場規模：用途別（再生医療＆治療法開発、創薬＆開発、臨床研究）...“The stem cell assays market is projected to reach USD 4.5 Billion by 2027 from USD 1.9 Billion in 2022, at a CAGR of 17.7% during the forecast period.” The growth of the market is projected to be driven by collaborations and agreements among market players for stem cell assay products & services, launch of new stem cell analysis systems such as flow cytometers and increase in R&D expenditure by biopharmaceutical and biotechnology companies. “The viability/cytotoxicity assays accounted for the largest share of the type segment in the stem cell assays market in 2021.” Cell viability assays help to determine...

医療用クラウドコンピューティングの世界市場予測（～2027）：製品別、展開別、コンポーネント別、価格別、サービス別、エンドユーザー別
HIT3561-22 / MarketsandMarkets / 2022年4月22日 / マーケッツアンドマーケッツ社は、世界の医療用クラウドコンピューティング市場規模が2022年394億ドルから2027年894億ドルまで、年平均17.8％成長すると予想しています。本市場調査資料では、医療用クラウドコンピューティングの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業インサイト、製品別（医療用プロバイダーソリューション、医療用ペイアーソリューション）分析、コンポーネント別（サービス、ソフトウェア）分析、展開形式別（プライベートクラウド、ハイブリッドクラウド、パブリッククラウド）分析、サービス形式別（サービスとしての（SaaS）、サービスとしてのインフラストラクチャ（SaaI）、サービスとしてのプラットフォーム（SaaP））分析、地域別分析、競争状況、企業情報などの項目を掲載しています。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・産業インサイト・世界の医療用クラウドコンピューティング市場規模：製品別（医療用プロバイダーソリューション、医療用ペイアーソリューション）・世界の医療用クラウドコンピューティング市場規模：コンポーネント別（サービス、ソフトウェア）・世界の医療用クラウドコンピューティング市場規模：展開形式別（プライベートクラウド、ハイブリッドクラウド、パブリッククラウド）...“The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%.” The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing,m health, wearlable devices, etc. “The healthcare provider solutions was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due...

バイオ除染のグローバル市場予測（～2027）：機器、サービス、消耗品
MD7164-22 / MarketsandMarkets / 2022年6月22日 / マーケッツアンドマーケッツ社は、世界のバイオ除染市場規模が、2022年159百万ドルから2027年227百万ドルまで年平均7.3％成長すると予測しています。本調査資料では、バイオ除染の世界市場について総合的に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別（機器、サービス、消耗品）分析、薬剤別（過酸化水素、二酸化塩素、過酢酸、二酸化窒素）分析、種類別（部屋除染、チャンバー除染）分析、エンドユーザー別（製薬＆医療機器製造会社、ライフサイエンス＆バイオテクノロジー研究機関、病院＆医療施設）分析、地域別分析、競争状況、企業情報などの内容をまとめております。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・世界のバイオ除染市場規模：製品・サービス別（機器、サービス、消耗品）・世界のバイオ除染市場規模：薬剤別（過酸化水素、二酸化塩素、過酢酸、二酸化窒素）・世界のバイオ除染市場規模：種類別（部屋除染、チャンバー除染）・世界のバイオ除染市場規模：エンドユーザー別（製薬＆医療機器製造会社、ライフサイエンス＆バイオテクノロジー研究機関、病院＆医療施設）...“The global bio decontamination market is projected to reach USD 227 million by 2027 from USD 159 million in 2022, at a CAGR of 7.3% from 2022 to 2027.” The increasing incidence of hospital-acquired infections, the increasing outsourcing of bio decontamination services, and presence of stringent regulation in pharmaceutical and medical device industry are the major factors driving the bio decontamination market. The chamber decontaminationsegment accounted for the highest growth rate in the bio decontamination market, by product, during the forecast period The global bio decontamination market is segmented into room decontamination and chamber decontamination based on type.The chamber decontaminationis...

外来用EHRのグローバル市場予測（～2027）：クラウドベース、オンプレミス
HIT5227-22 / MarketsandMarkets / 2022年6月16日 / マーケッツアンドマーケッツ社は、世界の外来用EHR市場規模が、2022年57億ドルから2027年77億ドルまで年平均6.1％成長すると予測しています。本調査資料では、外来用EHRの世界市場について総合的に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業洞察、デリバリー方式別（クラウドベース、オンプレミス）分析、用途別（診療管理、患者管理、電子処方、集団健康管理、その他）分析、診療規模別（大規模、中小規模、個人）分析、エンドユーザー別（病院所属外来センター、独立センター）分析、地域別分析、競争状況、企業情報などの内容をまとめております。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・産業洞察・世界の外来用EHR市場規模：デリバリー方式別（クラウドベース、オンプレミス）・世界の外来用EHR市場規模：用途別（診療管理、患者管理、電子処方、集団健康管理、その他）・世界の外来用EHR市場規模：診療規模別（大規模、中小規模、個人）...“The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period.” Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concernsare some of the challenges that are expected to limit the growth of the market to a certain extentduring the forecast period. “Cloud-basedwasthe fastest-growing segment in thedelivery mode ofambulatory EHR marketin 2021” Cloud-based segmentis projected to growth...

創薬における人工知能（AI）のグローバル市場予測（2022～2027）：ソフトウェア、サービス
HIT7445-22 / MarketsandMarkets / 2022年6月15日 / マーケッツアンドマーケッツ社は、世界の創薬における人工知能（AI）市場規模が、2022年6億ドルから2027年40億ドルまで年平均45.7％成長すると予測しています。本調査資料では、創薬における人工知能（AI）の世界市場について総合的に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、提供別（ソフトウェア、サービス）分析、技術別（機械学習、その他技術）分析、用途別（免疫・腫瘍、神経変性疾患、心血管疾患、代謝性疾患、その他）分析、エンドユーザー別（製薬＆バイオテクノロジー企業、CRO、研究センター＆学術・政府機関）分析、地域別分析、競争状況、企業情報などの内容をまとめております。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・世界の創薬における人工知能（AI）市場規模：提供別（ソフトウェア、サービス）・世界の創薬における人工知能（AI）市場規模：技術別（機械学習、その他技術）・世界の創薬における人工知能（AI）市場規模：用途別（免疫・腫瘍、神経変性疾患、心血管疾患、代謝性疾患、その他）・世界の創薬における人工知能（AI）市場規模：エンドユーザー別（製薬＆バイオテクノロジー企業、CRO、研究センター＆学術・政府機関）...“The Artificial intelligence/AI in drug discovery Market is projected to reach USD 4.0 billion by 2027 from USD 0.6 billion in 2022, at a CAGR of 45.7% during the forecast period.” The growth of this market is primarily driven by factors such as the need to control drug discovery & development costs and reduce the overall time taken in this process, the rising adoption of cloud-based applications and services. On the other hand, the inadequate availability of skilled labor is key factor restraining the market growt at certain extent over the forecast period. “Services segment is estimated to hold the...

テレヘルス＆テレメディシン（遠隔医療）の世界市場予測（～2027）：コンポーネント別、配信別、用途別、エンドユーザー別、地域別
HIT3542-22 / MarketsandMarkets / 2022年3月10日 / マーケッツアンドマーケッツ社は、世界のテレヘルス＆テレメディシン（遠隔医療）市場規模が、2022年878億ドルから2027年2,857億ドルまで年平均26.6％成長すると予測しています。本調査レポートは、テレヘルス＆テレメディシン（遠隔医療）の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、コンポーネント別（ソフトウェア＆サービス、ハードウェア）分析、配信別（クラウドベース、オンプレミス）分析、用途別（テレコンサルテーション、TeleICU、テレラジオロジー、テレストローク、テレダーマトロジー）分析、エンドユーザー別（提供者、支払者、患者、その他）分析、地域別分析、競争状況、企業情報など、以下の構成でまとめております。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・世界のテレヘルス＆テレメディシン（遠隔医療）市場規模：コンポーネント別（ソフトウェア＆サービス、ハードウェア）・世界のテレヘルス＆テレメディシン（遠隔医療）市場規模：配信別（クラウドベース、オンプレミス）・世界のテレヘルス＆テレメディシン（遠隔医療）市場規模：用途別（テレコンサルテーション、TeleICU、テレラジオロジー、テレストローク、テレダーマトロジー）・世界のテレヘルス＆テレメディシン（遠隔医療）市場規模：エンドユーザー別（提供者、支払者、患者、その他）...“The global telehealth & telemedicine market is expected to grow at a CAGR of 26.6% during the forecast period, to reach USD 285.7 billion by 2027 from an estimated USD 87.8 billion in 2022.” The key factors driving the growth of this market include the need to expand healthcare access, the growing prevalence of chronic diseases and conditions, a shortage of physicians, advancements in telecommunications, government support and raising awareness, and rising technology adoption in the wake of COVID-19. However, regional variations in regulations, fraud, and the use of social media for care providers will restrict the market growth during...

タンジェンシャルフローろ過（TFF）の世界市場予測（～2027）：製品別、材料別、技術別、用途別、エンドユーザー別、地域別
BT4615-22 / MarketsandMarkets / 2022年4月25日 / マーケッツアンドマーケッツ社は、世界のタンジェンシャルフローろ過（TFF）市場規模が2022年15億ドルから2027年28億ドルまで、年平均13.2％成長すると予想しています。本市場調査資料では、タンジェンシャルフローろ過（TFF）の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（使い捨て式システム、再利用可能式システム、膜フィルター、ろ過付属品）分析、膜材料別（PES、ポリフッ化ビニリデン（PVDF）、ナイロン、ポリテトラフルオロエチレン（PTFE）、混合セルロースエステル・セルロースアセテート（MCE・CA））分析、技術別（精密ろ過、限外ろ過、ナノフィルトレーション、その他）分析、用途別（最終製品処理、原材料ろ過、セル分離、浄水、空気清浄）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・世界のタンジェンシャルフローろ過（TFF）市場規模：製品別（使い捨て式システム、再利用可能式システム、膜フィルター、ろ過付属品）・世界のタンジェンシャルフローろ過（TFF）市場規模：膜材料別（PES、ポリフッ化ビニリデン（PVDF）、ナイロン、ポリテトラフルオロエチレン（PTFE）、混合セルロースエステル・セルロースアセテート（MCE・CA））・世界のタンジェンシャルフローろ過（TFF）市場規模：技術別（精密ろ過、限外ろ過、ナノフィルトレーション、その他）・世界のタンジェンシャルフローろ過（TFF）市場規模：用途別（最終製品処理、原材料ろ過、セル分離、浄水、空気清浄）...“The global tangential flow filtration market is projected to USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.2% during the forecast period.” The rising advantages of tangential flow filtration over normal flow filtration, increasing adoption of single-use technologies, and growing R&D spending in pharma-biotech companies. On the contrary, the high capital investments for setting up new production facilities are expected to restrain the market growth. “In 2021 the single-use systems segment accounted for the largest share of the tangential flow market.” The tangential flow filtration market is segmented into single-use systems, reusable systems,...

軟部組織修復の世界市場予測（～2027）：製品別、用途別
MD3215-22 / MarketsandMarkets / 2022年3月29日 / マーケッツアンドマーケッツ社は、世界の軟部組織修復市場規模が、2022年136億ドルから2027年172億ドルまで年平均4.7％成長すると予測しています。本調査資料では、軟部組織修復の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（組織パッチ/メッシュ、腹腔鏡器具）分析、用途別（ヘルニア修復、皮膚修復、整形外科修復、歯科修復、豊胸）分析、エンドユーザー別（病院、クリニック、その他）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・世界の軟部組織修復市場規模：製品別（組織パッチ/メッシュ、腹腔鏡器具）・世界の軟部組織修復市場規模：用途別（ヘルニア修復、皮膚修復、整形外科修復、歯科修復、豊胸）・世界の軟部組織修復市場規模：エンドユーザー別（病院、クリニック、その他）・世界の軟部組織修復市場規模：地域別...“MarketsandMarkets expects the soft tissue repair market is projected to reach USD 17.2Billion by 2027 from USD 13.6Billion in 2022, at a CAGR of 4.7% during the forecast period.” Growth in this market is mainly driven by Increasing aging population and obesity rate, growing incidence of sports injuries, strong focus on R&D leading to the launch of technologically advanced products, and increasing volume of surgeries and growing prevalence of severe trauma injuries. This, in turn, unfavorable reimbursement scenario and high price of soft tissue repair products and the rising cost of surgical procedures are the key factors restraining the growth...

動物用医療機器＆備品のグローバル市場予測（～2027）：消耗品、患者モニター、麻酔、輸液ポンプ
MD3898-22 / MarketsandMarkets / 2022年6月24日 / マーケッツアンドマーケッツ社は、世界の動物用医療機器＆備品市場規模が、2022年20億ドルから2027年29億ドルまで年平均8.1％成長すると予測しています。本調査資料では、動物用医療機器＆備品の世界市場について総合的に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（消耗品、麻酔装置、流体管理装置、体温管理装置、患者モニター）分析、用途別（手術用、診断・監視・治療用）分析、動物別（小型伴侶動物、大型動物、その他）分析、エンドユーザー別（動物病院、動物クリニック、動物医療研究機関）分析、地域別分析、競争状況、企業情報などの内容をまとめております。・イントロダクション・調査手法・エグゼクティブサマリー・プレミアムインサイト・市場概要・世界の動物用医療機器＆備品市場規模：種類別（消耗品、麻酔装置、流体管理装置、体温管理装置、患者モニター）・世界の動物用医療機器＆備品市場規模：用途別（手術用、診断・監視・治療用）・世界の動物用医療機器＆備品市場規模：動物別（小型伴侶動物、大型動物、その他）・世界の動物用医療機器＆備品市場規模：エンドユーザー別（動物病院、動物クリニック、動物医療研究機関）...Veterinary equipment and supplies include all kinds of medical equipment, which are intended to help diagnose, monitor, or treat various health conditions associated with animals, such as anesthetic medication, respiratory support, temperature management, and fluid management. It also includes disposable devices or the medical apparatus, which has been designed for temporary or one-time use, mainly for infection control. “The global veterinary equipment and supplies market is projected to reach USD 2.9 Billion by 2027 from USD 2.0 Billion in 2022, at a CAGR of 8.1% during the forecast period.” Emerging markets, such as rIndia and China, and growing companion animal...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆